Integral Diagnostics Management
Management Kriterienprüfungen 2/4
Integral Diagnostics' CEO ist Ian Kadish, ernannt in May 2017, hat eine Amtszeit von 7.08 Jahren. Die jährliche Gesamtvergütung beträgt A$1.10M, bestehend aus 71.2% Gehalt und 28.8% Boni, einschließlich Aktien und Optionen des Unternehmens. besitzt direkt 0.24% der Aktien des Unternehmens, im Wert von A$1.37M. Die durchschnittliche Betriebszugehörigkeit des Managementteams und des Verwaltungsrats beträgt 3.8 Jahre bzw. 1.9 Jahre.
Wichtige Informationen
Ian Kadish
Geschäftsführender
AU$1.1m
Gesamtvergütung
| Prozentsatz des Geschäftsführergehalts | 71.2% |
| Amtszeit als Geschäftsführer | 7.1yrs |
| Eigentum des Geschäftsführers | 0.2% |
| Durchschnittliche Amtszeit des Managements | 3.8yrs |
| Durchschnittliche Amtszeit der Vorstandsmitglieder | 1.9yrs |
Jüngste Management Updates
Recent updates
Some Investors May Be Worried About Integral Diagnostics' (ASX:IDX) Returns On Capital
Feb 21
Shareholders Will Probably Hold Off On Increasing Integral Diagnostics Limited's (ASX:IDX) CEO Compensation For The Time Being
Nov 22Integral Diagnostics' (ASX:IDX) Shareholders Will Receive A Smaller Dividend Than Last Year
Feb 20These 4 Measures Indicate That Integral Diagnostics (ASX:IDX) Is Using Debt Extensively
Dec 14Should You Think About Buying Integral Diagnostics Limited (ASX:IDX) Now?
May 26Integral Diagnostics (ASX:IDX) Is Paying Out Less In Dividends Than Last Year
Feb 28Integral Diagnostics Limited (ASX:IDX) Shares Could Be 38% Below Their Intrinsic Value Estimate
Feb 25Shareholders Would Not Be Objecting To Integral Diagnostics Limited's (ASX:IDX) CEO Compensation And Here's Why
Oct 29Does Integral Diagnostics (ASX:IDX) Deserve A Spot On Your Watchlist?
Sep 13An Intrinsic Calculation For Integral Diagnostics Limited (ASX:IDX) Suggests It's 22% Undervalued
Jun 04Should You Be Adding Integral Diagnostics (ASX:IDX) To Your Watchlist Today?
May 14Is Integral Diagnostics Limited (ASX:IDX) A Smart Choice For Dividend Investors?
May 03We Think Integral Diagnostics (ASX:IDX) Can Stay On Top Of Its Debt
Apr 16Is It Too Late To Consider Buying Integral Diagnostics Limited (ASX:IDX)?
Mar 27Is Integral Diagnostics Limited's (ASX:IDX) Stock's Recent Performance A Reflection Of Its Financial Health?
Mar 17The Trends At Integral Diagnostics (ASX:IDX) That You Should Know About
Mar 07Here's What We Like About Integral Diagnostics' (ASX:IDX) Upcoming Dividend
Feb 25Is Integral Diagnostics Limited (ASX:IDX) Popular Amongst Institutions?
Feb 23Have Insiders Been Selling Integral Diagnostics Limited (ASX:IDX) Shares?
Feb 13Integral Diagnostics Limited's (ASX:IDX) Intrinsic Value Is Potentially 46% Above Its Share Price
Feb 03
Here's What We Learned About The CEO Pay At Integral Diagnostics Limited (ASX:IDX)
Jan 24Should You Use Integral Diagnostics's (ASX:IDX) Statutory Earnings To Analyse It?
Jan 14Shareholders Of Integral Diagnostics (ASX:IDX) Must Be Happy With Their 201% Total Return
Jan 05Is Integral Diagnostics (ASX:IDX) A Risky Investment?
Dec 26At AU$4.30, Is It Time To Put Integral Diagnostics Limited (ASX:IDX) On Your Watch List?
Dec 17What To Know Before Buying Integral Diagnostics Limited (ASX:IDX) For Its Dividend
Dec 08Returns On Capital At Integral Diagnostics (ASX:IDX) Paint An Interesting Picture
Nov 29Is Integral Diagnostics Limited's (ASX:IDX) Shareholder Ownership Skewed Towards Insiders?
Nov 19Is Integral Diagnostics (ASX:IDX) A Risky Investment?
Sep 20Is It Too Late To Consider Buying Integral Diagnostics Limited (ASX:IDX)?
Sep 11Could Integral Diagnostics Limited (ASX:IDX) Have The Makings Of Another Dividend Aristocrat?
Sep 03Analyse der Geschäftsführervergütung
| Datum | Gesamtvergütung | Gehalt | Unternehmensgewinne |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -AU$58m |
| Sep 30 2023 | n/a | n/a | -AU$16m |
| Jun 30 2023 | AU$1m | AU$782k | AU$25m |
| Mar 31 2023 | n/a | n/a | AU$23m |
| Dec 31 2022 | n/a | n/a | AU$21m |
| Sep 30 2022 | n/a | n/a | AU$18m |
| Jun 30 2022 | n/a | AU$781k | AU$15m |
| Mar 31 2022 | n/a | n/a | AU$18m |
| Dec 31 2021 | n/a | n/a | AU$22m |
| Sep 30 2021 | n/a | n/a | AU$26m |
| Jun 30 2021 | AU$2m | AU$736k | AU$31m |
| Mar 31 2021 | n/a | n/a | AU$32m |
| Dec 31 2020 | n/a | n/a | AU$32m |
| Sep 30 2020 | n/a | n/a | AU$28m |
| Jun 30 2020 | AU$1m | AU$635k | AU$23m |
| Mar 31 2020 | n/a | n/a | AU$22m |
| Dec 31 2019 | n/a | n/a | AU$21m |
| Sep 30 2019 | n/a | n/a | AU$21m |
| Jun 30 2019 | AU$876k | AU$549k | AU$21m |
| Mar 31 2019 | n/a | n/a | AU$19m |
| Dec 31 2018 | n/a | n/a | AU$17m |
| Sep 30 2018 | n/a | n/a | AU$16m |
| Jun 30 2018 | AU$711k | AU$489k | AU$15m |
| Mar 31 2018 | n/a | n/a | AU$15m |
| Dec 31 2017 | n/a | n/a | AU$15m |
| Sep 30 2017 | n/a | n/a | AU$15m |
| Jun 30 2017 | AU$50k | AU$44k | AU$15m |
Vergütung im Vergleich zum Markt: IanDie Gesamtvergütung ($USD727.74K) liegt im Durchschnitt der Unternehmen ähnlicher Größe auf dem Markt Australian ($USD778.17K).
Entschädigung vs. Einkommen: IanDie Bezüge der Mitarbeiter sind gestiegen, während das Unternehmen unrentabel ist.
Geschäftsführer
Ian Kadish (61 yo)
7.1yrs
Amtszeit
AU$1,097,723
Vergütung
Dr. Ian Kadish, MBBCh, MBA, has been the Chief Executive Officer, Managing Director and Director at Integral Diagnostics Limited since May 22, 2017. Dr. Kadish serves as Independent Non-Executive Director...
Führungsteam
| Name | Position | Amtszeit | Vergütung | Eigentümerschaft |
|---|---|---|---|---|
| CEO, MD & Director | 7.1yrs | AU$1.10m | 0.24% A$ 1.5m | |
| Executive Director | 4.6yrs | AU$1.05m | 0.011% A$ 67.3k | |
| Chief Financial Officer | less than a year | keine Daten | keine Daten | |
| Chief Information Officer | 4.8yrs | keine Daten | keine Daten | |
| General Counsel & Company Secretary | less than a year | keine Daten | keine Daten | |
| Chief Medical Officer | 2.9yrs | keine Daten | keine Daten |
3.8yrs
Durchschnittliche Betriebszugehörigkeit
Erfahrenes Management: IDXDas Führungsteam des Unternehmens gilt als erfahren (3.7 Jahre durchschnittliche Betriebszugehörigkeit).
Vorstandsmitglieder
| Name | Position | Amtszeit | Vergütung | Eigentümerschaft |
|---|---|---|---|---|
| CEO, MD & Director | no data | AU$1.10m | 0.24% A$ 1.5m | |
| Executive Director | 4.6yrs | AU$1.05m | 0.011% A$ 67.3k | |
| Independent Non-Executive Director | 6.7yrs | AU$137.50k | 0.013% A$ 82.6k | |
| Independent Non-Executive Director | 1.9yrs | AU$131.77k | 0.036% A$ 227.0k | |
| Independent Non-Executive Director | less than a year | keine Daten | 0.015% A$ 93.4k | |
| Independent Non-Executive Director | less than a year | keine Daten | 0.065% A$ 405.1k |
1.9yrs
Durchschnittliche Betriebszugehörigkeit
59yo
Durchschnittliches Alter
Erfahrener Vorstand: IDXDie Vorstandsmitglieder gelten nicht als erfahren ( 1.8 Jahre durchschnittliche Amtszeit), was auf einen neuen Vorstand hindeutet.